Tech Company Financing Transactions
Vigil Neuroscience Funding Round
Vigil Neuroscience, operating out of Cambridge, received $50 million in investment from Atlas Venture, Northpond Ventures and Alexandria Venture Investments.
Transaction Overview
Company Name
Announced On
12/9/2020
Transaction Type
Venture Equity
Amount
$50,000,000
Round
Series A
Investors
Atlas Venture (Lead Investor) (Bruce Booth)
Northpond Ventures (Lead Investor)
Proceeds Purpose
Vigil will use the Series A funds to progress its lead pipeline candidate, a monoclonal antibody TREM2 agonist, through Phase 1 studies, advance their small molecule TREM2 agonist to IND, as well as pursue additional assets to grow the pipeline and increase the body of data supporting microglia biology as an important therapeutic pathway.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
300 Technology Sq. 8th Floor
Cambridge, MA 02139
USA
Cambridge, MA 02139
USA
Phone
Website
Email Address
Overview
We are discovering and developing novel therapeutics that take advantage of breakthroughs in basic science and human genetics of microglia. Vigil's drug pipeline consists of therapeutic candidates targeting critical microglial signaling pathways in which loss-of-function mutations cause life-threatening neurodegenerative diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Ivana Magovcevic-Liebisch
Chief Financial Officer
Jennifer Ziolkowski
Chief Medical Officer
Spyros Papapetropoulos
Chief Scientific Officer
Richard Fisher
Controller
Pam Meneses
Vice President
Jessica Stromme
VP - Bus. Development
Evan Thackaberry
VP - Operations
Andrew Marsh
VP - Operations
Weeteck Yeo
VP - Regulatory Affairs
Samantha Zappia
Browse more venture capital transactions:
Prev: 12/9/2020: GoHenry venture capital transaction
Next: 12/9/2020: Quell venture capital transaction
Share this article
About Database of VC Transactions
We do our best to document all VC transactions involving tech companies. All VC database entries on this site are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs